未登录.png)
分享.png)
收藏分享 收藏 Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers
Zhao, Xinmin; Wu, Xianghua; Wang, Huijie; Yu, Hui; Sun, Si; Hu, Zhihuang; Lin, Ying; Zhang, Yao; Yu, Bo; Wu, Zhenhua; Xiong, Kangli; Liu, Cuicui; Wang, Song; Bao, Hua; Ou, Qiuxiang; Wang, Jialei 分享 收藏 Impulse control deficits among patients with nonsuicidal self-injury: a mediation analysis based on structural imaging非自杀性自伤患者冲动控制缺陷：一项基于结构成像的中介分析Xie, Ya; Wu, Sichu; Li, Jian; Zhang, Congjie; Zhang, Yumin; Hang, Yaming; Lang, Nan; Lv, Zhangwei; Zhang, Pei; Liang, Minlu; Yu, Bo; Long, Jing; Liu, Yuan; Wang, Suhong; Ouyang, Lichen; Zhang, Liping; Wu, Yun 分享 收藏 EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAF V600E mutation: a multi-center real-world experience in ChinaYang, Wenyue; Feng, Xiangran; Ni, Jian; Zhang, Xin; Yu, Hui; Wu, Xianghua; Wang, Huijie; Zhao, Xinmin; Hu, Zhihuang; Yu, Bo; Zhang, Yao; Lin, Ying; Xiang, Yi; Wang, Jialei 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
